Aiatella, a Helsinki, Finland-based medtech startup, raised €2M in funding.
The spherical was led by Nordic Science Investments, with participation from Specialist VC, Harjavalta Ventures, Enterprise Finland, and a syndicate of angel traders.
The corporate intends to make use of the funds to increase operations and its R&D efforts.
Led by CEO Jack Parker, Aiatella gives a multi-modal Automated Picture Measurement (AIM) know-how that makes use of pictures from prevalent applied sciences like MRI, CT, and ultrasound to analyse vascular imaging, detecting, and quantifying abnormalities and adjustments over time in at-risk sufferers. Automated evaluation makes these duties take minutes, permitting clinicians to focus extra on affected person care.
The corporate is at the moment in medical approval processes in a number of nations throughout Europe and North America, together with the UK, France, and the USA.
FinSMEs
04/06/2025
